Odylia is building a centralized marketplace to ensure critical resources are findable and accessible for patient groups and other members of the rare disease research community. Ultimately, centralizing these resources will decrease wasted time and money, and increase the speed at which drugs are developed for rare diseases. Driven by the complexity in connecting the disparate pieces of drug development, The Odylia Collective will connect patient groups and the research community with a growing collection of service providers including: manufacturers, clinical CROs, animal testing, cell line producers, biobanking services, and more.
Help us shape the ecosystem you wish existed today
Are you a patient group, rare disease patient, family member, academic researcher, or other member of the rare disease community focused on developing novel therapeutics and struggling to find or access resources? Register your interest here and be the first to explore the new platform at launch.
How does The Odylia Marketplace serve the rare disease patient community?
Service providers, whether companies or individuals, will gain access to a network of rare disease groups, each at various stages of research or therapeutic development. Reasons to join: